Baltimore jurors will decide if two drug companies should pay the city over $260 million for their role in the opioid crisis. City lawyers argue the companies prioritized profit over public health by oversupplying opioids, leading residents to turn to more potent drugs.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing